EU’s SCCS Reissues Guidance On Cosmetic Ingredient Testing With Updated Non-Animal Method Perspectives
This article was originally published in The Rose Sheet
The Scientific Committee on Consumer Safety’s guidance offers perspective on new approach methodologies that can be used to substantiate cosmetic ingredient safety, as well as areas where alternative strategies continue to be insufficient. The document also includes updated criteria for multi-constituent natural ingredients at a time of increasing industry use.
You may also be interested in...
The European Commission’s Scientific Committee for Consumer Safety has been unable to get the data it needs to properly assess the safety of nanomaterials in cosmetic products. The European Commission expects REACH to address the issue, and that is probably not a prospect that industry stakeholders relish.
South Korea’s Ministry of Food and Drug Safety and Taiwan’s Food and Drug Administration will transition from ICCR observers to full members, joining regulatory authorities from the US, Europe, Japan, Canada and Brazil. PCPC’s Francine Lamoriello, EVP of global affairs, discusses.
Industry no doubt welcomes the Commission’s long-overdue review of the European Cosmetics Regulation as it pertains to chemicals with endocrine-disrupting properties. The report concludes that the existing regulatory framework is adequate to evaluate and manage suspected endocrine disruptors, while putting stakeholders on notice that a number of prioritized ingredients will be up for review in 2019.